[1] | A. Boeijen, J.A. Kruijtzer, R.M. Liskamp, “Combinatorial chemistry of hydantoins”, Bioorg. Med. Chem. Lett. 8, 2375-2380, 1998. |
[2] | K.H. Park, J. Ehrler, H. Spoerri, M.J. Kurth, “Preparation of a 990-member chemical compound library of hydantoin- and isoxazoline-containing heterocycles using multipin technology”, J. Comb. Chem. 3, 171-176, 2001. |
[3] | M.J. Lin, C.M. Sun, “Microwave-assisted traceless synthesis of thiohydantoin”, Tetrahedron Lett. 44, 8739-8742, 2003. |
[4] | W. Zhang, Y.M. Lu, C.H.T Chen, L. Zeng, D.B. Kassel, “Fluorous mixture synthesis of two libraries with hydantoin-, and benzodiazepinedione-fused heterocyclic scaffolds”, J. Comb. Chem. 8, 687-695, 2006. |
[5] | E. Mutschler, H. Derendorf, “Drug Actions, Basic Principles and Therapeutic Aspects”, Medpharm Scientific Publishers, Stuttgart, 1995. |
[6] | J. Knabe, J. Baldauf, A. Ahlhem, “Racemates and enantiomers of basic substituted 5-phenylhydantoins. Syntheses and antiarrhythmic activity“. Pharmazie, 52, 912-919, 1997. |
[7] | T. Dylag, M. Zygmunt, D. Maciag, J. Handzlik, M. Bednarski, B. Filipek, K. Kiec-Kononowicz, “Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives”. Eur. J. Med. Chem. 39, 1013-1027, 2004. |
[8] | N. Opacic, M. Barbarić, B. Zorc, M. Cetina, A. Nagl, D. Frkovic, M. Kralj, K. Pavelic, J. Balzarini, G. Andrei, R. Snoeck, E. De Clercq, S. Raić-Malić, M. Mintas, “The novel L- and D-Amino acid derivatives of hydroxyurea and hydantoins: Synthesis, X-ray crystal structure study, and cytostatic and antiviral activity evaluations,” J. Med. Chem. 48, 475-482, 2005. |
[9] | E. Lattmann, W.O. Ayuko, D. Kinchinaton, C.A. Langley, H. Singh, L. Karimi, M.J. Tisdale, “Synthesis and evaluation of 5-arylated 2(5H)-furanones and 2-arylated pyridazin-3(2H)-ones as anti-cancer agents”, J. Phar. Pharmacol. 55, 1259-1265, 2003. |
[10] | C. Carmi, A. Cavazzoni, V. Zuliani, A. Lodola, F. Bordi, P.V. Plazzi, R.R. Alfieri, P.G. Petronini, M. Mor, “5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity”, Bioorg. Med. Chem. Lett. 16, 4021-4025, 2006. |
[11] | G. Singh, P.H. Driever, J.W. Sander, L. Sander, “Cancer risk in people with epilepsy: The role of antiepileptic drugs”, Brain 128, 7-17, 2005. |
[12] | A.M. Kaindl, S. Asimiadou, D. Manthey, H.V.D. Hagen, V.D. Turski, C. Ikonomidou, “Antiepileptic drugs and the developing brain”, Cell. Mol. Life Sci. 63, 399-413, 2006. |
[13] | H.H. Merrit, T.J. Putnam, “A new series of anticonvulsant drugs tested by experiments on animals”, Arch. Neurol. Psychiatry 39, 1003-1015, 1938. |
[14] | J.E. Tompkins, “5,5-diaryl-2-thiohydantoins and 5,5-diaryl N3-substituted 2-thiohydantoins as potential hypolipidemic agents”, J. Med. Chem., 29, 855-859, 1986. |
[15] | A. Takahashi, H. Matsuoka, K. Yamada, Y. Uda, “Characterization of antimutagenic mechanism of 3-allyl-5-substituted 2-thiohydantoins against 2-amino-3-methylimidazo[4,5-f]quinoline”, Food and Chem. Toxicology, 43, 521-528, 2005. |
[16] | S. Al-Madi, A.M. Al-Obaid, H. El-Subbagh, “The in vitro antitumor assay of 5-(Z)-arylidene-4-imidazolidinones in screens of AIDS-related leukemia and lymphomas”, AntiCancer Drugs, 12, 835-839, 2001. |
[17] | M. Shiozaki, “Syntheses of hydantocidin and C-2-thioxohydantocidin”, Carbohydr. Res. 337, 2077-2088, 2002. |
[18] | J. Marton, J. Enisz, S. Hosztafi, T. Timar, “Preparation and fungicidal activity of 5-substituted hydantoins and their 2-thio analogs,” J. Agric. Food. Chem. 41, 148-152, 1993. |
[19] | J. Vázquez, M. Royo, F. Albericio, “Re-evaluation of a solid-phase hydantoin synthesis”. Lett. Org. Chem. 1, 224-226, 2004. |
[20] | Z.D. Wang, S.O. Sheikh, Y.L. Zhang, “A simple synthesis of 2-thiohydantoins”, Molecules, 11, 739-750, 2006. |
[21] | S. Reyes, K. Burgess, “On formation of thiohydantoins from amino acids under acylation conditions”. J. Org. Chem. 71, 2507-2509, 2006. |
[22] | G.E. Delgado, A.J. Mora, J. Uzcátegui, A. Bahsas, A. Briceño, “(S)-5-benzylimidazolidine-2,4-dione monohydrate”, Acta Cryst. C63, 448-450, 2007. |
[23] | G.E. Delgado, L.E Seijas, A.J. Mora, T. Gonzalez, A. Briceño, “Synthesis, crystal structure and hydrogen-bonding patterns in (RS)-1-carbamoyl pyrrolidine-2-carboxylic acid”. J. Chem. Cryst. 42, 388-393, 2012. |
[24] | G.E. Delgado, L.E Seijas, A.J. Mora, “Synthesis and crystal structure determination of hydanotin-L-proline”. J. Chem. Cryst. 2012. DOI 10.1007/s10870-012-0344-3. |
[25] | L.E. Seijas, G. E. Delgado, A.J. Mora, A. Bahsas, J. Uzcátegui, “Síntesis y caracterización de los derivados N-carbamoilo e hidantoina de L-prolina”, Av. Quím. 1, 3-7, 2006. |
[26] | L.E. Seijas, G. E. Delgado, A.J. Mora, A. Bahsas, A. Briceño, “(2S)-1-carbamoylpyrrolidine-2-carboxylic acid”, Acta Cryst. C63, o303-o305, 2007. |
[27] | L.E. Seijas, A.J. Mora, G.E. Delgado, M. Brunelli, A.N. Fitch, “Study of the conversion of N-carbamoyl-L-proline to hydantoin-L-proline using powder synchrotron X-ray diffraction”, Powder Diffr. 25, 342-348, 2010. |
[28] | M.E. Sulbaran, G.E. Delgado, A.J. Mora, A. Bahsas, H. Novoa de Armas, N. Blaton. “Hydrogen-bonding patterns in rac-1-acetyl-5-methyl-2-thioxoimidazolidine-4-one”. Acta Cryst. C63, o543-o545, 2007. |
[29] | X-ray Single Crystal Analysis System (XSCANS), Version 2.2; Siemens Analytical X-ray Instruments Inc.: Madison, WI, USA, 1996. |
[30] | G.M. Sheldrick, “A short history of SHELX”, Acta Cryst. A64, 112-122, 2008. |
[31] | G. Bergerhoff, M. Berndt, K. Brandenburg, “Evaluation of Crystallographic Data with the Program DIAMOND”, J. Res. Natl. Inst. Stand. Technol. 101, 221-225, 1996. |
[32] | A.L. Spek, “Single-crystal structure validation with the program Platon”, J. Appl. Cryst. 36, 7-13, 2003. |
[33] | R. Yoshioka, “Racemization, optical resolution and crystallization-induced asymmetric transformation of amino acids and pharmaceutical intermediates”. Top. Curr. Chem. 269, 83-132, 2007. |
[34] | F.H. Allen, “The cambridge structral database: a quarter of a million crystal structures and rising”, Acta Cryst. B58, 380-388, 2002. |
[35] | M.F. Mackay, B.M. Duggan, R.L. Laslett, J.F.K. Wilshire, “Structure of a substituted 2-thiohydantoin,”. Acta Cryst. C48, 334-336, 1992. |
[36] | J.S. Casas, A. Castañeiras, D. Couce, N. Playá, J. Sordo, J.M. Varela, “1-acetyl-2-thiohydantoin,”. Acta Cryst. C54, 427-428, 1998. |
[37] | M.C. Etter, “Encoding and decoding hydrogen-bond patterns of organic-compounds” Acc. Chem. Res. 23, 120-126, 1990. |